Sarepta Therapeutics, Inc. (NASDAQ:SRPT) Q1 2024 Earnings Call Transcript May 1, 2024 Sarepta Therapeutics, Inc. beats earnings expectations. Reported EPS is $0.37, expectations were $-0.11. Sarepta Therapeutics, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good afternoon and welcome […]
It is difficult to describe the emotion of getting out on our America’s Cup boat for the first time on Wednesday.
‘Literal-minded people don’t understand it’s a joke,’ comedy star said
Thru | Total | ||
---|---|---|---|
6 | -5 | ||
7 | -4 | ||
3 | -2 | ||
8 | -2 | ||
7 | -2 | ||
4 | -2 | ||
6 | -2 | ||
7 | -2 | ||
4 | -2 | ||
6 | -2 |